Article: Research and Markets : This is The Only Product That Provides You with a Comprehensive Picture of the Development of Cancer Vaccines.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c19295) has announced the addition of Analytical Tool - Cancer Vaccine to their offering.

This is our second analytical tool in the cancer vaccine field, now more updated and extensive. We have since several years continuously studied the progress in cancer immunotherapy strategies. So far "passive" immunotherapy has experienced most success, with antibody and cytokine therapy leading the way. Among the strategies utilizing an active immunotherapy approach it is evident that cell-based vaccines have made most progress. Positive data has been forth coming for a whole cell melanoma ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!